VEGF and TMR: myocardial revascularization in the next millennium.
Futterman
L G
LG
Department of Medicine, University of Miami School of Medicine, Fla. 33101, USA.
Lemberg
L
L
D000368:Aged; D000787:Angina Pectoris / Q000628:therapy*; D003131:Combined Modality Therapy; D016228:Endothelial Growth Factors / Q000235:genetics / Q000627:therapeutic use*; D005544:Forecasting; D018014:Gene Transfer Techniques / Q000639:trends; D006801:Humans; D053685:Laser Therapy / Q000379:methods* / Q000639:trends; D008222:Lymphokines / Q000235:genetics / Q000627:therapeutic use*; D008297:Male; D009204:Myocardial Revascularization / Q000379:methods* / Q000639:trends; D018579:Patient Selection; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors